Dyadic International (DYAI) Competitors $1.14 +0.01 (+0.88%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DYAI vs. IXHL, ACTU, CCCC, PYXS, CTOR, THTX, ACOG, GLSI, NVCT, and NKTXShould you be buying Dyadic International stock or one of its competitors? The main competitors of Dyadic International include Incannex Healthcare (IXHL), Actuate Therapeutics (ACTU), C4 Therapeutics (CCCC), Pyxis Oncology (PYXS), Citius Oncology (CTOR), Theratechnologies (THTX), Alpha Cognition (ACOG), Greenwich LifeSciences (GLSI), Nuvectis Pharma (NVCT), and Nkarta (NKTX). These companies are all part of the "pharmaceutical products" industry. Dyadic International vs. Its Competitors Incannex Healthcare Actuate Therapeutics C4 Therapeutics Pyxis Oncology Citius Oncology Theratechnologies Alpha Cognition Greenwich LifeSciences Nuvectis Pharma Nkarta Incannex Healthcare (NASDAQ:IXHL) and Dyadic International (NASDAQ:DYAI) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, institutional ownership, valuation, earnings, analyst recommendations, media sentiment, dividends and profitability. Do analysts prefer IXHL or DYAI? Dyadic International has a consensus target price of $6.00, suggesting a potential upside of 425.85%. Given Dyadic International's stronger consensus rating and higher probable upside, analysts plainly believe Dyadic International is more favorable than Incannex Healthcare.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Incannex Healthcare 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00Dyadic International 1 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Which has stronger earnings and valuation, IXHL or DYAI? Dyadic International has higher revenue and earnings than Incannex Healthcare. Dyadic International is trading at a lower price-to-earnings ratio than Incannex Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioIncannex Healthcare$86K1,694.06-$46.88M-$1.21-0.35Dyadic International$3.42M12.07-$5.81M-$0.19-6.01 Do insiders and institutionals hold more shares of IXHL or DYAI? 0.4% of Incannex Healthcare shares are held by institutional investors. Comparatively, 28.0% of Dyadic International shares are held by institutional investors. 15.5% of Incannex Healthcare shares are held by insiders. Comparatively, 29.5% of Dyadic International shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is IXHL or DYAI more profitable? Incannex Healthcare has a net margin of 0.00% compared to Dyadic International's net margin of -134.84%. Dyadic International's return on equity of -355.39% beat Incannex Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets Incannex HealthcareN/A -671.36% -298.35% Dyadic International -134.84%-355.39%-60.66% Which has more risk and volatility, IXHL or DYAI? Incannex Healthcare has a beta of 7.5, meaning that its stock price is 650% more volatile than the S&P 500. Comparatively, Dyadic International has a beta of 1, meaning that its stock price has a similar volatility profile to the S&P 500. Does the media favor IXHL or DYAI? In the previous week, Incannex Healthcare and Incannex Healthcare both had 3 articles in the media. Incannex Healthcare's average media sentiment score of 0.00 equaled Dyadic International'saverage media sentiment score. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Incannex Healthcare 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Dyadic International 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryDyadic International beats Incannex Healthcare on 10 of the 14 factors compared between the two stocks. Get Dyadic International News Delivered to You Automatically Sign up to receive the latest news and ratings for DYAI and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DYAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYAI vs. The Competition Export to ExcelMetricDyadic InternationalMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$41.29M$12.26B$9.05B$10.60BDividend YieldN/A2.28%5.69%4.71%P/E Ratio-6.0121.5785.8527.35Price / Sales12.07275.71535.75201.60Price / CashN/A47.1237.9261.55Price / Book14.2610.4213.056.78Net Income-$5.81M-$52.40M$3.30B$275.79M7 Day Performance-6.48%6.37%4.79%2.63%1 Month Performance16.33%16.15%9.97%9.12%1 Year Performance0.97%33.92%85.15%35.86% Dyadic International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYAIDyadic International2.6051 of 5 stars$1.14+1.0%$6.00+425.9%-4.2%$41.29M$3.42M-6.017Positive NewsAnalyst ForecastIXHLIncannex Healthcare0.3813 of 5 stars$0.44-7.7%N/A-72.3%$167.52M$90K-0.373News CoverageAnalyst ForecastShort Interest ↓ACTUActuate Therapeutics1.7794 of 5 stars$7.02+0.6%$20.33+189.6%+0.9%$162.24MN/A0.0010Analyst ForecastCCCCC4 Therapeutics3.5443 of 5 stars$2.28+0.4%$8.50+272.8%-56.5%$161.56M$35.58M-1.44150Analyst ForecastPYXSPyxis Oncology1.9685 of 5 stars$2.47-3.9%$7.75+213.8%-12.1%$159.39M$16.15M-1.5460News CoverageAnalyst ForecastCTORCitius Oncology3.1252 of 5 stars$1.87-1.1%$6.00+220.9%+78.6%$157.84MN/A0.00N/ANews CoverageAnalyst ForecastGap UpTHTXTheratechnologiesN/A$3.42+0.9%N/A+182.6%$157.21M$84.38M-17.99140High Trading VolumeACOGAlpha Cognition3.2753 of 5 stars$7.40-1.1%$20.00+170.3%N/A$156.35MN/A-4.63N/APositive NewsGLSIGreenwich LifeSciences1.126 of 5 stars$11.28+3.4%$42.00+272.3%-15.6%$153.75MN/A-8.293NVCTNuvectis Pharma2.5984 of 5 stars$6.05+0.7%$15.33+153.4%+3.3%$152.87MN/A-5.178News CoverageAnalyst ForecastNKTXNkarta2.1967 of 5 stars$2.15+0.9%$13.60+532.6%-46.4%$152.70MN/A-1.45140News CoverageAnalyst ForecastHigh Trading Volume Related Companies and Tools Related Companies Incannex Healthcare Alternatives Actuate Therapeutics Alternatives C4 Therapeutics Alternatives Pyxis Oncology Alternatives Citius Oncology Alternatives Theratechnologies Alternatives Alpha Cognition Alternatives Greenwich LifeSciences Alternatives Nuvectis Pharma Alternatives Nkarta Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DYAI) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredForget AI, This Will Be the Next Big Tech BreakthroughAfter picking Nvidia in 2016, before it jumped 27,000%... Jeff Brown is back with what he believes will be ...Brownstone Research | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dyadic International Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dyadic International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
